M. Mennecozzi

发表

A biologybased biologybased biologybased dynamic approach for the modelling of toxicity in cell-based assays . Part I : Fate modelling

J. Zaldívar, M. Bouhifd, M. Mennecozzi, 2010 .

HER-2/neu oncogene sequence revisited.

F. Venanzi, A. Concetti, L. Soverchia, 2002, Journal of the National Cancer Institute.

Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy

James W. Young, E. Romano, J. Shyer, 2013, Journal of Translational Medicine.

Tumor endothelial marker 8 enhances tumor immunity in conjunction with immnization against differentiation Ag.

K. Manova, A. Houghton, F. Venanzi, 2007, Cytotherapy.

Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase.

Antonella Isacchi, Riccardo Colombo, Enrico Pesenti, 2010, Cancer research.

Iron oxide nanoparticle toxicity testing using high-throughput analysis and high-content imaging

Maria Dusinska, Maurice Whelan, Georgina Harris, 2015, Nanotoxicology.

Adverse Outcome Pathway-based Screening Strategies for an Animal-free Safety Assessment of Chemicals

Brigitte Landesmann, Elisabet Berggren, Maurice Whelan, 2013, Alternatives to laboratory animals : ATLA.

Sex Differences in Liver Toxicity—Do Female and Male Human Primary Hepatocytes React Differently to Toxicants In Vitro?

M. Whelan, T. Palosaari, B. Landesmann, 2015, PloS one.

A human pluripotent carcinoma stem cell-based model for in vitro developmental neurotoxicity testing: Effects of methylmercury, lead and aluminum evaluated by gene expression studies

A. Bal-Price, D. Pamies, G. Pallocca, 2013, International Journal of Developmental Neuroscience.

MicroRNA profiling as a tool for pathway analysis in a human in vitro model for neural development.

L. Gribaldo, M Mennecozzi, K. Vojnits, 2012, Current medicinal chemistry.

Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy

James W. Young, E. Romano, J. Shyer, 2013, Journal of Translational Medicine.

Bispecific antibody target pair discovery by high-throughput phenotypic screening using in vitro combinatorial Fab libraries

Laura E Starkie, H. Finney, B. Twomey, 2021, mAbs.

Three-dimensional HepaRG model as an attractive tool for toxicity testing.

Sandra Coecke, Iwona Wilk-Zasadna, Claude Guillou, 2012, Toxicological sciences : an official journal of the Society of Toxicology.

Development of a pluripotent stem cell derived neuronal model to identify chemically induced pathway perturbations in relation to neurotoxicity: effects of CREB pathway inhibition.

G. Basso, B. Accordi, F. Pistollato, 2014, Toxicology and applied pharmacology.

Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag.

K. Manova, A. Houghton, F. Venanzi, 2007, Cytotherapy.

Practical use of the Virtual Cell Based Assay: Simulation of repeated exposure experiments in liver cell lines.

A Worth, A Paini, T. Palosaari, 2017, Toxicology in vitro : an international journal published in association with BIBRA.

Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase.

A. Isacchi, S. R. Depaolini, F. Colotta, 2010, Cancer Research.